Welcome to LookChem.com Sign In|Join Free

CAS

  • or

163250-90-6

Post Buying Request

163250-90-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

163250-90-6 Usage

Uses

Antithrombotic; platelet aggregation inhibitor.

Check Digit Verification of cas no

The CAS Registry Mumber 163250-90-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,2,5 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 163250-90:
(8*1)+(7*6)+(6*3)+(5*2)+(4*5)+(3*0)+(2*9)+(1*0)=116
116 % 10 = 6
So 163250-90-6 is a valid CAS Registry Number.
InChI:InChI=1/C17H25N5O3/c1-2-25-15(23)7-9-20-17(24)21-13-8-10-22(11-13)14-5-3-12(4-6-14)16(18)19/h3-6,13H,2,7-11H2,1H3,(H3,18,19)(H2,20,21,24)

163250-90-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 3-[[(3S)-1-(4-carbamimidoylphenyl)-2-oxopyrrolidin-3-yl]carbamoylamino]propanoate

1.2 Other means of identification

Product number -
Other names Orbofiban

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:163250-90-6 SDS

163250-90-6Downstream Products

163250-90-6Relevant articles and documents

Platelet aggregation inhibitors

-

, (2008/06/13)

This invention relates to compounds having the following formula STR1 or a pharmaceutically acceptable salt thereof which are useful in the inhibition of platelet aggregation, to pharmaceutical compositions of such phenylamidines derivatives, and to a method of inhibiting platelet aggregation in mammals by administering such compounds and compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 163250-90-6